Yoland C Antill Clinical Oncology Society of Australia Annual Scientific Meeting 2023

Abstracts this author is presenting:

• The impact of cause of mismatch repair deficiency and other molecular markers on clinical outcomes with the use of durvalumab in advanced endometrial cancer in the phase 2 PHAEDRA trial (ANZGOG1601). — Best of the Best Oral Presentations - Gynaecological Cancer